Estonia - Estonia - Ravimiamet

organon n.v. - mometasoon - nahalahus - 1mg 1g 20ml 1tk; 1mg 1g 50ml 1tk

Estonia - Estonia - Ravimiamet

organon n.v. - mometasoon - salv - 1mg 1g 20g 1tk; 1mg 1g 50g 1tk

Estonia - Estonia - Ravimiamet

organon n.v. - mometasoon - ninasprei, suspensioon - 50mcg 1annus 140annus 2tk; 50mcg 1annus 140annus 1tk

Estonia - Estonia - Ravimiamet

organon n.v. - etonogestreel - implantaat - 68mg 5tk; 68mg 1tk

Estonia - Estonia - Ravimiamet

organon n.v. - mirtasapiin - suus dispergeeruv tablett - 15mg 48tk; 15mg 96tk

Estonia - Estonia - Ravimiamet

organon n.v. - levodopa+karbidopa - toimeainet prolongeeritult vabastav tablett - 200mg+50mg 100tk

Estonia - Estonia - Ravimiamet

organon n.v. - testosteroon - pehmekapsel - 40mg 60tk

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoos, postmenopausis - narkootikumid luuhaiguste raviks - menopausijärgse osteoporoosi ravi d-vitamiini puudulikkusega patsientidel. adrovance vähendab lülisamba ja puusaluu murrud.

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

n.v. organon - desloratadine, pseudophedrine sulfate - riniit, allergiline, hooajaline - nina preparaadid - hooajalise allergilise riniidi sümptomaatiline ravi, kui sellega kaasneb ninakinnisus.

Kesatuan Eropah - Estonia - EMA (European Medicines Agency)

n.v. organon - korifollitropiin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - suguhormoonid ja genitaalsüsteemi, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).